Falcorp has refined and reinvented its approach to graduate training to integrate structured mentorship, experiential learning and a focus on organisational culture and personal development, to help ...

The state aims to increase software exports from Rs 4.09 lakh crore to Rs 11.5 lakh crore by 2030. Karnataka, the pioneer of India’s IT revolution, has approved a new Information Technology Policy ...

Multi-Cancer Testing - Hype or Hope? Adoption: The Blame Game An unholy row over bishop accused of bullying. 11 November 2025 38 minutes Available for over a year An ambitious plan to digitalize the ...

As per Punjab Chief Minister Maryam Nawaz Sharif’s vision, government is taking important steps to fulfill her dream of a digital Punjab. A remarkable effort has been made to connect IT graduates with ...

Currently, the Python extension only supports “Run Selection/Line in Native Python REPL”. However, there is no built-in command to run the entire file in the Native Python REPL environment, similar to ...

Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...

The fate of a once-promising cancer treatment now looks uncertain at best. The meeting was conducted with U.S. Food and Drug Administration (FDA) officials, and it took place on Tuesday. The subject ...

Replimune Group, Inc. received a surprising FDA Complete Response Letter for RP1, citing inadequate trial design and concerns over data interpretation. RP1's delayed approval and the need for a new ...

NEW YORK--(BUSINESS WIRE)--Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Replimune Group, Inc. (NASDAQ: REPL) for potential violations of the federal ...

Replimune Group, Inc. (NASDAQ:REPL) stock plunged on Tuesday after a U.S. Food and Drug Administration (FDA) update. The clinical stage biotechnology company received an FDA Complete Response Letter ...

Multiple analysts have issued price targets for $REPL recently. We have seen 4 analysts offer price targets for $REPL in the last 6 months, with a median target of ...